吸入抗病毒药物的干粉:治疗呼吸道病毒病原体的有希望的方法
Tushar Saha1, Zia Uddin Masum2, Anik Biswas3
1Mastaplex Ltd., Centre for Innovation, University of Otago, Dunedin 9016, New Zealand.
Viruses
|February 26, 2025
概括
与传统口服药物相比,吸入式干粉抗病毒药物可提供针对性呼吸道感染治疗,提高疗效并减少副作用. 这种方法可以提高药物直接输送到肺部,以更好地管理病毒性疾病.
科学领域:
- 制药科学 制药科学
- 呼吸系统医学 呼吸系统医学
- 传染性疾病 传染性疾病
背景情况:
- 对呼吸道感染的传统口服抗病毒疗法存在局限性,包括全身副作用和延迟作用.
- 针对性地向呼吸道输送药物对于有效管理局部病毒感染至关重要.
研究的目的:
- 审查呼吸道病毒感染的吸入干粉抗病毒药物的现状.
- 突出干粉吸入器 (DPI) 与传统的注射途径相比的优势.
- 总结现有和新兴的吸入干粉抗病毒配方.
主要方法:
- 出版和销售的吸入干粉抗病毒药物的文献综述.
- 对DPI的制定策略和交付机制的分析.
- 对吸入抗病毒药物的治疗益处和挑战的评估.
主要成果:
- 吸入的干粉抗病毒药物可以直接给呼吸道,增强药物沉积和治疗疗效.
- 这种有针对性的方法最大限度地减少了全身暴露和相关的副作用.
- 目前正在开发各种DPI配方,有望改善治疗结果.
结论:
- 吸入式干粉配方在治疗呼吸道病毒感染方面取得了重大进展.
- 由于其增强的疗效和安全性,DPI为口服抗病毒药物提供了优质的替代品.
- 在这个领域进行进一步的研究和开发,有可能为变革性疗法提供潜力.
相关概念视频
Inhaled Medications
218
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
218
Drugs Used in Upper Respiratory Disorders: Overview
174
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
174
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
218
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
218
Drugs Used in Lower Respiratory Disorders: Overview
335
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
335
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
209
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
209
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K


